+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Myopia & Presbyopia Eye Drops Market, by Eye Drops, by Indication, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

  • PDF Icon

    Report

  • 178 Pages
  • September 2021
  • Region: Global
  • Coherent Market Insights Pvt Ltd.
  • ID: 5456043
Presbyopia is an eye disorder, in which one’s eyes gradually lose the ability to see things clearly up close distances. It is a normal part of aging. In addition, myopia is a common eye disorder that cause vision loss, and uncorrected myopia is amongst the leading cause of distance vision impairment worldwide. Several individual studies have shown variations in the prevalence of high myopia and myopia in regions and ethnic groups, and there continues to be uncertainty regarding increasing prevalence of myopia. Moreover, market players are focused on inorganic strategies such as partnerships, in order to increase awareness about childhood myopia which in turn is expected to boost the market growth over the forecast period. For instance, in October 2020, Myopia Profile Pty Ltd and Essilor International entered into a partnership agreement for empowering eye care practitioners with skills, clinical knowledge, and practice in managing childhood myopia. The partnership will also boost public awareness of the consequences of myopia, also called near sightedness, and in addition, this will also encourage parents to have their children’s vision tested.



Market Dynamics


Researchers are focusing on research and development activities for the development of new treatment for myopia and presbyopia, by using new technologies, which is expected to drive growth of the global myopia & presbyopia eye drops market over the forecast period. For instance, in January 2019, Bar-Ilan University’s Institute of Nanotechnology and Advanced Materials (BINA), Israel, developed eye drops called as ‘nanodrops’ for correcting the refractive-related vision problems such as myopia and presbyopia. The eye drops are made up of a synthetic nanoparticle solution and have been tested on pig’s cornea. The researchers reported that the drops treated two kinds of refractive errors: myopia and presbyopia in pigs.

Key features of the study:

  • This report provides an in-depth analysis of the global myopia & presbyopia eye drops market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2021-2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global myopia & presbyopia eye drops market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, strategies
  • Key companies covered as a part of this study include Orasis Pharmaceuticals, AbbVie Inc. (Allergan), Novartis AG, OSRX Pharmaceuticals, LENZ Therapeutics, Visus Therapeutics, Ocuphire Pharma Inc., Eyenovia, Inc., Vyluma Inc., and Jawa Pharmaceuticals (India) Pvt. Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global myopia & presbyopia eye drops market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the global myopia & presbyopia eye drops market

Detailed Segmentation:


Global Myopia & Presbyopia Eye Drops Market, By Eye Drops:

  • Atropine Drops
  • Pipeline Products
  • CSF-1
  • AGN - 190584
  • Nyxol
  • UNR844-Cl
  • PRX-100
  • MicroLine
  • Others

Global Myopia & Presbyopia Eye Drops Market, By Indication:

  • Myopia
  • Presbyopia

Global Myopia & Presbyopia Eye Drops Market, By End User:

  • Hospitals
  • Ophthalmic Clinics
  • Others

Global Myopia & Presbyopia Eye Drops Market, By Region:

  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Country/Region
  • South Africa
  • Central Africa
  • North Africa

Company Profiles

  • Orasis Pharmaceuticals*
  • Company Highlights
  • Products Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • AbbVie Inc. (Allergan)
  • Novartis AG
  • OSRX Pharmaceuticals
  • LENZ Therapeutics
  • Visus Therapeutics
  • Ocuphire Pharma Inc.
  • Eyenovia, Inc.
  • Vyluma Inc.
  • Jawa Pharmaceuticals (India) Pvt. Ltd.
Frequently Asked Questions about the Myopia & Presbyopia Eye Drops Market

What is the estimated value of the Myopia & Presbyopia Eye Drops Market?

The Myopia & Presbyopia Eye Drops Market was estimated to be valued at $52.7 Million in 2021.

What is the growth rate of the Myopia & Presbyopia Eye Drops Market?

The growth rate of the Myopia & Presbyopia Eye Drops Market is 88.7%, with an estimated value of $4494.6 Million by 2028.

What is the forecasted size of the Myopia & Presbyopia Eye Drops Market?

The Myopia & Presbyopia Eye Drops Market is estimated to be worth $4494.6 Million by 2028.

Who are the key companies in the Myopia & Presbyopia Eye Drops Market?

Key companies in the Myopia & Presbyopia Eye Drops Market include Orasis Pharmaceuticals, AbbVie Inc. (Allergan), Novartis AG, OSRX Pharmaceuticals, LENZ Therapeutics, Visus Therapeutics, Ocuphire Pharma Inc., Eyenovia Inc. and Jawa Pharmaceuticals (India) Pvt. Ltd..

Table of Contents

1. Research Objectives and Assumptions
  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview
  • Report Description
  • Market Definition and Scope
  • Executive Summary
  • Market Snapshot, By Eye Drops
  • Market Snapshot, By Indication
  • Market Snapshot, By End User
  • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis
  • Market Dynamics
  • Drivers
  • Restraints
  • Opportunity
  • Impact Analysis
  • Industry Trends
  • Mergers and Acquisitions
  • Technology Overview
  • Regulation Scenario
  • Key Developments
  • Recent Approvals
  • PEST Analysis
  • Epidemiology
  • Pipeline Analysis

4. Global Myopia & Presbyopia Eye Drops Market- Impact of Coronavirus (COVID-19) Pandemic
  • Impact of COVID-19 on Supply and Demand
  • Impact of COVID-19 on Research and Development
  • Impact of COVID-19 on Overall Healthcare Market

5. Global Myopia & Presbyopia Eye Drops Market, By Eye Drops, 2017 - 2028, (US$ Mn)
  • Introduction
  • Market Share Analysis, 2021 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
  • Atropine Drops
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Pipeline Products
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • CSF-1
  • AGN-190584
  • Nyxol
  • UNR844-Cl
  • PRX-100
  • MicroLine
  • Others

6. Global Myopia & Presbyopia Eye Drops Market, By Indication, 2017 - 2028, (US$ Mn)
  • Introduction
  • Market Share Analysis, 2021 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
  • Myopia
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Presbyopia
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

7. Global Myopia & Presbyopia Eye Drops Market, By End User, 2017 - 2028, (US$ Mn)
  • Introduction
  • Market Share Analysis, 2021 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
  • Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Ophthalmic Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

8. Global Myopia & Presbyopia Eye Drops Market, By Region, 2017 - 2028, (US$ Mn)
  • Introduction
  • Market Share Analysis, By Region, 2021 and 2028 (%)
  • Y-o-Y Growth Analysis, For Regions, 2017-2028
  • Regional Trends
  • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Eye Drops, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 - 2028, (US$ Mn)
  • U.S.
  • Canada
  • Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Eye Drops, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 - 2028, (US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Eye Drops, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 - 2028, (US$ Mn)
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Eye Drops, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 - 2028, (US$ Mn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Eye Drops, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 - 2028, (US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Eye Drops, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Countries/Region, 2017 - 2028, (US$ Mn)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape
  • Heat Map Analysis
  • Market Share Analysis
  • Orasis Pharmaceuticals
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • AbbVie Inc. (Allergan)
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Novartis AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • OSRX Pharmaceuticals
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • LENZ Therapeutics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Visus Therapeutics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Ocuphire Pharma Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Eyenovia, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Vyluma Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Jawa Pharmaceuticals (India) Pvt. Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Analyst Views

10. Section
  • Research Methodology
  • About us

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Orasis Pharmaceuticals
  • AbbVie Inc. (Allergan)
  • Novartis AG
  • OSRX Pharmaceuticals
  • LENZ Therapeutics
  • Visus Therapeutics
  • Ocuphire Pharma Inc.
  • Eyenovia Inc.
  • Vyluma Inc.
  • Jawa Pharmaceuticals (India) Pvt. Ltd.